Lakey Jonathan R T, Burridge Philip W, Shapiro A M James
Surgical-Medical Research Institute, 1074 Dentistry/Pharmacy Centre, T6G 2N8, Edmonton, Alberta, Canada.
Transpl Int. 2003 Sep;16(9):613-32. doi: 10.1007/s00147-003-0651-x. Epub 2003 Aug 19.
The introduction of insulin therapy for the management of diabetes mellitus is arguably the greatest milestone in the history of modern medicine. beta-cell replacement therapy is the only treatment that reestablishes and maintains long-term physiological normoglycemia. Until recently, successful clinical outcomes of pancreas transplantation for patients with long-standing diabetes were much superior to that of islet transplantation. Significant advances in islet isolation and purification technology, the development of more specific and less diabetogenic immunosuppressants and the prophylactic administration of antiviral agents have rekindled a worldwide interest in islet transplantation. This chapter will review the rationale of islet transplantation and the development of islet isolation and purification. The challenges facing clinical islet transplantation in the twenty-first century will also be introduced.
胰岛素疗法用于糖尿病管理的引入,可以说是现代医学史上最伟大的里程碑。β细胞替代疗法是唯一能够重建并维持长期生理性血糖正常的治疗方法。直到最近,长期糖尿病患者胰腺移植的成功临床结果仍远优于胰岛移植。胰岛分离和纯化技术的重大进展、更具特异性且致糖尿病作用较小的免疫抑制剂的开发以及抗病毒药物的预防性给药,重新燃起了全球对胰岛移植的兴趣。本章将回顾胰岛移植的基本原理以及胰岛分离和纯化的发展历程。还将介绍21世纪临床胰岛移植所面临的挑战。